|Videos|November 4, 2017

Providers: Be Assertive When Recommending Flu Vaccination to Older Adults

William Schaffner, MD, explains how health care providers can work towards getting patients who are aged 65 and older to receive a flu shot.

William Schaffner, MD, medical director for the National Foundation for Infectious Diseases’ (NFID) and infectious disease physician at Vanderbilt, explains how health care providers can work towards getting patients who are aged 65 and older to receive a flu shot.

Interview Transcript (modified slightly for readability):

[So, what about] the role of the provider, and physicians for sure, but also pharmacists, and everyone else who deals with the public? It is said that we should recommend influenza vaccine to everyone because the recommendations say that everyone older than 6 months of age should be vaccinated each and every year against influenza.

But a recommendation can be made very casually. ‘Oh, Tom, it’s that time of the year. You ought to think about getting your flu vaccine.’ That’s a recommendation? That’s giving the patient permission to decline vaccination. We don’t say that about the treatment of diabetes. ‘Oh, you ought to think about getting your diabetes treated, Tom.’

We need to insist on vaccination. We need to say, ‘It’s that time of the year; we vaccinate everyone in our practice.’ And if you get pushback, look at the patient in a kind of an alarmed way and say, ‘I’ve been vaccinated. My whole family has been vaccinated. Everybody in the office has been vaccinated. Tom, we’re going to vaccinate you before you go home.’ Because it’s so important to do everything we can to prevent influenza, and if we are more assertive rather than just casually recommending, I think we’ll vaccinate many, many more people.

You’d be surprised how many people have a health care encounter during the fall and leave the doctor’s office, the pharmacy, or wherever, unvaccinated. That shouldn’t happen.”


Related to this article

Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.
The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.